Effect of miR-133b on progression and cisplatin resistance of triple-negative breast cancer through FGFR1-Wnt-β-catenin axis

pubmed: wnt1 2021-09-03

Summary:

CONCLUSION: To sum up, miR-133b can inhibit the growth and DDP resistance of TNBC cells by targeting FGFR1 and inactivating the Wnt-β-catenin pathway.

Link:

https://pubmed.ncbi.nlm.nih.gov/34306338/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=16uwQpOeqFYN8R4TKOtwPy2utpqy9ex2oldalD2yF_fQHv2caq&fc=None&ff=20210903123324&v=2.14.5

From feeds:

Exome » pubmed: wnt1

Authors:

Yan Lin, Fengkang Lin, Songyot Anuchapreeda, Rujirek Chaiwongsa, Suwit Duangmano, Bing Ran, Sakorn Pornprasert

Date tagged:

09/03/2021, 12:33

Date published:

07/26/2021, 06:00